Jing Li

机构：Fujian Medical University, Georgia Institute of Technology, The University of Texas MD Anderson Cancer Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Chengdu University of Information Technology, Fudan University, IQVIA (United Kingdom), University Hospital Regensburg, Zhengzhou University, Shanghai Stomatological Hospital, Ministry of Education, Fourth Affiliated Hospital of China Medical University, First Affiliated Hospital of Fujian Medical University, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Zhengzhou Central Hospital, Panzhihua Central Hospital, Henan Cancer Hospital, Wuhan Sixth Hospital, IQ Solutions, Fu Wai Hospital, Chongqing Medical and Pharmaceutical College, Jiangxi University of Finance and Economics, University of Regensburg, Texas A&M University, China Medical University · ORCID：0000-0002-8840-8638

发表论文 307 篇 · 总被引 5234 次 · h-index 36

代表论文

• Benefit–harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials (2025 · The Lancet · 被引 42)
• Fusobacterium in the microbiome: from health to disease across the oral–gut axis and beyond (2025 · npj Biofilms and Microbiomes · 被引 37)
• Cardioprotective Effects of Semaglutide on Isolated Human Ventricular Myocardium (2025 · European Journal of Heart Failure · 被引 26)
• Effect of Intensive Blood Pressure Control on Stroke (2025 · Journal of the American College of Cardiology · 被引 10)
• Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy (2025 · JAMA Oncology · 被引 9)
• Development of a clinical prediction model for intra-abdominal infection in severe acute pancreatitis using logistic regression and nomogram (2025 · Frontiers in Medicine · 被引 3)